The global renal denervation market size was US$ 220,109 thousand in 2021. The global renal denervation market size is forecast to reach US$ 4,565,983.0 thousand by 2030, growing at a compound annual growth rate (CAGR) of 40.8% during the forecast period from 2022 to 2030. 

Renal denervation reduces hypertension through a minimally invasive catheter-based procedure. Radiofrequency ablation burns the nerves in the kidney arteries. In addition, this reduces nerve activity and lowers blood pressure. In most cases, the operation occurs after multiple attempts at pharmacological therapy have failed. The nerves of the renal artery wall are ablating with radiofrequency pulses of ultrasound. It lowers blood pressure by decreasing sympathetic kidney activity.

Factors Influencing Market Growth

• A growing number of changes in lifestyle that cause resistant hypertension and an increase in hypertension prevalence have led to an expansion of the global renal denervation market.
• A technological advancement that has led to the development of alternative technologies for renal denervation systems, such as micro-infusion, has propelled growth in the global renal denervation market. 
• Strict regulatory requirements for the devices and negative reimbursements for the procedure may slow down the overall market growth.

Impact Analysis of COVID-19

The COVID-19 pandemic had negatively impacted the global renal denervation market growth due to social distancing measures enacted by governments worldwide. The availability of hospitals and medical services had been severely limited. In addition, the COVID-19 pandemic has significantly affected the global economy and the functioning of general hospital treatment for non-COVID-19 patients in hospitals worldwide. COVID-19 outbreak has forced a number of medical device makers to postpone or delay the launch of their products due to a lack of resources and funding.

Regional Insights

Europe accounted for the highest share in the market in 2021. As a result of the increase in R&D activities to develop more efficient devices. A growing number of cases of drug-resistant hypertension will also contribute to the growth of the region. Furthermore, device approvals in the European region are forecast to support the market growth.

The Asia Pacific is forecast to have the highest growth rate over the forecast period. As a result of the many unmet medical needs related to hypertension, the increased awareness of advanced technologies, such as renal denervation systems, and the high prevalence of resistant hypertension, thus these factors are forecast to offer lucrative opportunities for the market in the region.

Leading Competitors

The leading prominent companies profiled in the global renal denervation market are:

• Ablative Solutions, Incorporated
• Abbott Laboratories
• Johnson & Johnson
• Cardiosonic Incorporated
• Boston Scientific Corporation
• Medtronic plc
• Mercator MedSystems, Incorporated
• ReCor Medical, Incorporated
• Renal Dynamics Limited
• Terumo corporation
• Other Prominent Players

Scope of the Report

The global renal denervation market segmentation focuses on Product Type, Technology, End-User, and Region.

Segmentation based on Product Type

• Symplicity
• EnligHTN 
• Vessix
• Paradise
• Iberis
• Others

Segmentation based on Technology

• Radiofrequency
• Ultrasound
• Micro-Infusion

Segmentation based on End-User

• Hospitals
• Specialty Clinics
• Others

Segmentation based on Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America

Meta Title: Renal Denervation Market Size, Share, insight And Forecast 2022 To 2030

Meta Description: The Global renal denervation market is projected to reach US$ 4,565,983.0 thousand by end of 2030 from US$ 220,109 thousand in 2021, at a CAGR of 40.8%

Meta Keywords: renal denervation market Size, renal denervation market share, renal denervation market trend, renal denervation market Forecast, renal denervation market insight